GlaxoSmithKline | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
Alcon AG USD 6.31B 10M 2024-12
Almirall EUR 693.24M 29.14M 2024-06
Amgen USD 29.03B 2.26B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Fresenius EUR 11.45B 219M 2024-12
Fresenius Medical Care EUR 7.92B 168.26M 2024-12
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 27.85B 4.16B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
GRIFOLS EUR 5.73B 404.28M 2024-12
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Lonza CHF 5.44B 113M 2024-12
Merck EUR 13.45B 479M 2024-12
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Novo Nordisk 195.16B 17.66B 2024-09
Orion EUR 1.08B 67.7M 2025-03
Pfizer USD 50.36B 7.14B 2024-12
Philips EUR 10.02B 116M 2024-12
Recordati EUR 1.26B 10.61M 2024-09
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Smith & Nephew USD 4.42B 37M 2024-12
UCB EUR 4.79B 1.47B 2024-12



GlaxoSmithKline Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.